Genomic medicine for cancer prognosis

Aarti Mathur, Martha A. Zeiger

Research output: Contribution to journalArticle

Abstract

There is a heavy research emphasis on prognostic and predictive approaches based on genomic data, which has in turn challenged standard paradigms for the management of patients with malignant disease. This review will highlight the recent advances made in genomic medicine, specifically with regard to prognosis associated with thyroid cancer, cutaneous melanoma, and pancreatic adenocarcinoma. Although none of the markers reviewed have been incorporated into routine clinical practice, this review covers the most promising ones.

LanguageEnglish (US)
Pages31-37
Number of pages7
JournalJournal of Surgical Oncology
Volume111
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Skin Neoplasms
Thyroid Neoplasms
Melanoma
Adenocarcinoma
Medicine
Research
Neoplasms

Keywords

  • BRAF
  • Genomic medicine
  • Prognosis

ASJC Scopus subject areas

  • Surgery
  • Oncology
  • Medicine(all)

Cite this

Genomic medicine for cancer prognosis. / Mathur, Aarti; Zeiger, Martha A.

In: Journal of Surgical Oncology, Vol. 111, No. 1, 01.01.2015, p. 31-37.

Research output: Contribution to journalArticle

Mathur A, Zeiger MA. Genomic medicine for cancer prognosis. Journal of Surgical Oncology. 2015 Jan 1;111(1):31-37. Available from, DOI: 10.1002/jso.23734
Mathur, Aarti ; Zeiger, Martha A./ Genomic medicine for cancer prognosis. In: Journal of Surgical Oncology. 2015 ; Vol. 111, No. 1. pp. 31-37
@article{e7061184403d48e2bb6b536200d21276,
title = "Genomic medicine for cancer prognosis",
abstract = "There is a heavy research emphasis on prognostic and predictive approaches based on genomic data, which has in turn challenged standard paradigms for the management of patients with malignant disease. This review will highlight the recent advances made in genomic medicine, specifically with regard to prognosis associated with thyroid cancer, cutaneous melanoma, and pancreatic adenocarcinoma. Although none of the markers reviewed have been incorporated into routine clinical practice, this review covers the most promising ones.",
keywords = "BRAF, Genomic medicine, Prognosis",
author = "Aarti Mathur and Zeiger, {Martha A.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1002/jso.23734",
language = "English (US)",
volume = "111",
pages = "31--37",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Genomic medicine for cancer prognosis

AU - Mathur,Aarti

AU - Zeiger,Martha A.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - There is a heavy research emphasis on prognostic and predictive approaches based on genomic data, which has in turn challenged standard paradigms for the management of patients with malignant disease. This review will highlight the recent advances made in genomic medicine, specifically with regard to prognosis associated with thyroid cancer, cutaneous melanoma, and pancreatic adenocarcinoma. Although none of the markers reviewed have been incorporated into routine clinical practice, this review covers the most promising ones.

AB - There is a heavy research emphasis on prognostic and predictive approaches based on genomic data, which has in turn challenged standard paradigms for the management of patients with malignant disease. This review will highlight the recent advances made in genomic medicine, specifically with regard to prognosis associated with thyroid cancer, cutaneous melanoma, and pancreatic adenocarcinoma. Although none of the markers reviewed have been incorporated into routine clinical practice, this review covers the most promising ones.

KW - BRAF

KW - Genomic medicine

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=84919999368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919999368&partnerID=8YFLogxK

U2 - 10.1002/jso.23734

DO - 10.1002/jso.23734

M3 - Article

VL - 111

SP - 31

EP - 37

JO - Journal of Surgical Oncology

T2 - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 1

ER -